22/12/2023
We are thrilled to announce the release of our new cDAT application for automated quantification of DAT SPECT images in Europe!
With the CE mark certification, our advanced cNeuro platform now supports the diagnostics of Parkinson's disease.
Our groundbreaking cDAT application assists in the detection of loss of functional dopaminergic neuron terminals in the striatum, aiding in the diagnosis of diseases associated with dopaminergic deficiencies like Parkinson's disease and Dementia with Lewy Bodies (DLB).
At Combinostics, we are dedicated to providing innovative solutions that empower healthcare professionals and enhance patient care. By automating the quantification of DAT SPECT images, we aim to streamline the diagnostic process.
To learn more about this technology, visit our website: https://eu1.hubs.ly/H06M1XQ0